Implanet's JAZZ sales increased 30% in 2017 — 7 highlights

Megan Wood -   Print  |

Implanet reported its fourth quarter and full-year revenue for 2017.

Here are seven highlights:


1. In the fourth quarter, Implanet reported $2.33 million in revenue. The knee business took a 27 percent dive in the quarter, due to the planned ending of arthroscopy implant distribution.


2. The JAZZ business reached $1.47 million in revenue in the fourth quarter, with the number of sold units increasing 16 percent to 2,821.


3. The company saw 2017 revenue of $9.58 million.


4. The 2017 full-year JAZZ sales increased 30 percent to 9,117 units, hitting $5.77 million, a 15 percent increase over 2016. The JAZZ business captures 60 percent of the company's total revenue.


5. Implanet sold 1,537 JAZZ units in the U.S., reflecting a 6 percent boost and $2.46 million in revenue for 2017.


6. In 2017, Implanet sold 4,101 JAZZ units in France, totaling $1.84 million in revenue.


7. The company sold 3,479 JAZZ units in the rest of the world in 2017, reflecting a 58 percent boost from the year prior.


More articles on devices:
J&J’s 2017 full-year orthopedics sales fall flat, spine business line sales drop: 5 things to know
Europe spinal implants market to hit $3.8B by 2024 — 4 observations
19 spine, orthopedic device companies to impact the industry in 2018


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers